HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L'Oreal Kicks Off FY 2016 With Consumer Biz Acceleration, NA Share Gains

This article was originally published in The Rose Sheet

Executive Summary

Firm reports 4.2% like-for-like growth for the fiscal 2016 first quarter, driven by improvements in North America and the best performance from its Consumer Products division in almost three years. Analysts see the results as an affirmation that L'Oreal's competitive edge remains sharp.

You may also be interested in...



L’Oreal’s Logocos Naturkosmetik Acquisition: A Shot In The Arm For Consumer Division?

L’Oreal aims to expand the German company’s Logona and Sante brands internationally, which could help accelerate growth in its Consumer Products business. Division head Alexis Perakis-Valat says the deal harnesses “one of today’s major beauty ascending trends.”

In Brief: L’Oreal Acquires IT Cosmetics, Provides Microbeads Update; More

L’Oreal adds IT Cosmetics to its thriving Luxe business for $1.2bn in cash. Unilever offers perspective on its Dollar Shave Club acquisition during its Q1 earnings call.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019898

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel